Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: December 17, 2012
Last updated: July 9, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2015
  Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: May 28, 2015